Form 4: LifeStance CTO Executes Tax-Related Share Withholding

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Technology Officer Vukasin Paunovich reported the withholding of 17,456 shares to satisfy tax obligations upon RSU vesting.

Summary

  • Vukasin Paunovich, Chief Technology Officer of LifeStance Health Group, Inc., engaged in a net settlement transaction on June 11, 2026.
  • The transaction involved the withholding of 17,456 shares of common stock by the company to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
  • Following this transaction, the reporting person maintains beneficial ownership of 291,840 shares of common stock.
  • The transaction was executed at a price of $8.61 per share.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event, as it is a routine tax-related transaction and not an open-market sale.

Positives

  • The transaction was a mandatory tax withholding event rather than an open-market sale, indicating no change in the executive's long-term confidence in the company.

Negatives

  • The transaction resulted in a reduction of the executive's total shareholdings.

Risks

  • None identified; this is a routine administrative transaction related to equity compensation.

Future Outlook

No forward-looking guidance provided in this filing.

Management Comments

  • The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.

Industry Context

StockSavvy.ai notes that net settlement transactions are standard practice for corporate executives to manage tax liabilities associated with equity-based compensation plans, and this filing does not signal a change in corporate strategy or executive sentiment.

Comparison to Industry Standards

  • The transaction follows standard corporate governance practices for equity compensation management consistent with other publicly traded healthcare technology firms.

Stakeholder Impact

  • Minimal impact on shareholders as the transaction is a standard tax-related settlement.

Next Steps

  • None indicated.

Key Dates

DateDescription
06/11/2026Date of RSU vesting and share withholding transaction.
06/15/2026Date of filing for the Form 4.

Keywords

LifeStance Health, LFST, Insider Transaction, Form 4, Equity Compensation, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.